McElhenny Sheffield Capital Management LLC Makes New Investment in iShares Biotechnology ETF $IBB

McElhenny Sheffield Capital Management LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 150,503 shares of the financial services provider’s stock, valued at approximately $25,400,000. iShares Biotechnology ETF makes up 6.2% of McElhenny Sheffield Capital Management LLC’s investment portfolio, making the stock its 5th biggest holding. McElhenny Sheffield Capital Management LLC owned approximately 0.30% of iShares Biotechnology ETF at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of IBB. Brighton Jones LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $201,000. AQR Capital Management LLC purchased a new stake in iShares Biotechnology ETF during the first quarter worth $455,000. Millennium Management LLC boosted its position in iShares Biotechnology ETF by 140.8% during the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. M&T Bank Corp boosted its position in iShares Biotechnology ETF by 39.3% during the second quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares in the last quarter. Finally, Walleye Capital LLC boosted its position in iShares Biotechnology ETF by 26.8% during the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after purchasing an additional 985 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 2.0%

IBB opened at $171.86 on Thursday. The business’s fifty day moving average is $170.23 and its two-hundred day moving average is $165.71. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a $0.1218 dividend. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.